Web Stats Provided By Google Analytics

Thursday, August 22, 2013

Inovio Pharmaceuticals' Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models

With these strong preclinical results, Inovio plans to initiate a phase I/IIa clinical trial next year .

http://www.hispanicbusiness.com/2013/8/22/inovio_pharmaceuticals_malaria_dna_vaccine_demonstrates.htm

No comments:

Post a Comment